233 related articles for article (PubMed ID: 36986430)
1. Inhibiting
Sakyi PO; Kwofie SK; Tuekpe JK; Gwira TM; Broni E; Miller WA; Wilson MD; Amewu RK
Pharmaceuticals (Basel); 2023 Feb; 16(3):. PubMed ID: 36986430
[TBL] [Abstract][Full Text] [Related]
2. Homology Modeling,
Sakyi PO; Broni E; Amewu RK; Miller WA; Wilson MD; Kwofie SK
Front Cell Infect Microbiol; 2022; 12():859981. PubMed ID: 35719359
[TBL] [Abstract][Full Text] [Related]
3. A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of
Broni E; Kwofie SK; Asiedu SO; Miller WA; Wilson MD
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803906
[TBL] [Abstract][Full Text] [Related]
4. Repurposing of FDA-approved drugs as inhibitors of sterol C-24 methyltransferase of Leishmania donovani to fight against leishmaniasis.
Tabrez S; Rahman F; Ali R; Muhammad F; Alshehri BM; Alaidarous MA; Banawas S; Dukhyil AAB; Rub A
Drug Dev Res; 2021 Dec; 82(8):1154-1161. PubMed ID: 33929761
[TBL] [Abstract][Full Text] [Related]
5. Virtual screening of natural compounds for potential inhibitors of Sterol C-24 methyltransferase of Leishmania donovani to overcome leishmaniasis.
Rahman F; Tabrez S; Ali R; Akand SK; Zahid M; Alaidarous MA; Alsaweed M; Alshehri BM; Banawas S; Bin Dukhyil AA; Rub A
J Cell Biochem; 2021 May; ():. PubMed ID: 33955051
[TBL] [Abstract][Full Text] [Related]
6. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
7. Computational study to discover potent phytochemical inhibitors against drug target, squalene synthase from
Wadanambi PM; Mannapperuma U
Heliyon; 2021 Jun; 7(6):e07178. PubMed ID: 34141935
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhizic acid attenuates growth of Leishmania donovani by depleting ergosterol levels.
Dinesh N; Neelagiri S; Kumar V; Singh S
Exp Parasitol; 2017 May; 176():21-29. PubMed ID: 28242356
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Antileishmanial Potential of
Tabrez S; Rahman F; Ali R; Alouffi AS; Alshehri BM; Alshammari FA; Alaidarous MA; Banawas S; Bin Dukhyil AA; Rub A
ACS Omega; 2021 Jan; 6(3):2318-2327. PubMed ID: 33521470
[No Abstract] [Full Text] [Related]
10. Identification of
Phan TN; Park KP; Shum D; No JH
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675653
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis.
Rub A; Shaker K; Kashif M; Arish M; Dukhyil AAB; Alshehri BM; Alaidarous MA; Banawas S; Amir K
Protein Pept Lett; 2019; 26(5):371-376. PubMed ID: 30827222
[TBL] [Abstract][Full Text] [Related]
12. Structure-based drug designing against
Sarma M; Borkotoky S; Dubey VK
J Biomol Struct Dyn; 2023 Jul; ():1-9. PubMed ID: 37491862
[TBL] [Abstract][Full Text] [Related]
13. Antileishmanial effect of mevastatin is due to interference with sterol metabolism.
Dinesh N; Soumya N; Singh S
Parasitol Res; 2015 Oct; 114(10):3873-83. PubMed ID: 26183607
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening.
Phan TN; Park KP; Benítez D; Comini MA; Shum D; No JH
Biochem Biophys Res Commun; 2022 Dec; 637():308-313. PubMed ID: 36413853
[TBL] [Abstract][Full Text] [Related]
15. Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani.
Singh S; Dinesh N; Kaur PK; Shamiulla B
Parasitol Res; 2014 Jun; 113(6):2161-8. PubMed ID: 24728519
[TBL] [Abstract][Full Text] [Related]
16. Targeting sterol alpha-14 demethylase of Leishmania donovani to fight against leishmaniasis.
Tabrez S; Rahman F; Ali R; Akand SK; Alaidarous MA; Alshehri BM; Banawas S; Dukhyil AAB; Rub A
J Cell Biochem; 2021 Apr; ():. PubMed ID: 33817826
[TBL] [Abstract][Full Text] [Related]
17. In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferase.
Kant V; Kumar P; Ranjan R; Kumar P; Mandal D; Vijayakumar S
Parasitol Res; 2022 Jul; 121(7):2093-2109. PubMed ID: 35536513
[TBL] [Abstract][Full Text] [Related]
18. Imipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole.
Andrade-Neto VV; Pereira TM; Canto-Cavalheiro Md; Torres-Santos EC
Parasit Vectors; 2016 Mar; 9():183. PubMed ID: 27036654
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.
Kashif M; Tabrez S; Husein A; Arish M; Kalaiarasan P; Manna PP; Subbarao N; Akhter Y; Rub A
J Cell Biochem; 2018 Mar; 119(3):2653-2665. PubMed ID: 29058760
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Antileishmanial Activity and
de Aquino TM; França PHB; Rodrigues ÉEES; Nascimento IJS; Santos-Júnior PFS; Aquino PGV; Santos MS; Queiroz AC; Araújo MV; Alexandre-Moreira MS; Rodrigues RRL; Rodrigues KAF; Freitas JD; Bricard J; Meneghetti MR; Bourguignon JJ; Schmitt M; da Silva-Júnior EF; de Araújo-Júnior JX
Med Chem; 2022; 18(2):151-169. PubMed ID: 33593264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
